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Key Points  
 Functional disorders (i.e., interstitial cystitis/painful bladder syndrome and irritable bowel 
syndrome) are associated with hyperexcitability of afferent nerves innervating the urinary 
tract and the bowel respectively.   
Various non-5-HT3 receptor mRNA transcripts are expressed in mouse urothelium and 
exert functional responses to 5-HT. 
 Whilst 5-HT3 receptors were not detected in mouse urothelium, 5-HT3 receptors expressed 
on bladder sensory neurons plays a role in bladder afferent excitability under both normal 
conditions and in a mouse model of chronic visceral hypersensitivity (CVH). 
These data suggest that the role 5-HT3 receptors play in bladder afferent signaling 
warrants further study as a potential therapeutic target for functional bladder disorders. 
Nipaporn Konthapakdee obtained a Ph.D. degree in Biomedical Science from the University of 
Sheffield, United Kingdom. She received a full scholarship from the Development and Promotion of 
Sciences and Technology Talents Project (DPST), Thailand. Currently, she works as a lecturer at the 
Department of Physiology, Faculty of Science, Prince of Songkla University, Thailand. Her current 
research focuses on neural mechanisms related to functional disorders in the bowel and the urinary 
bladder.  
Abstract 
Serotonin (5-HT) is an excitatory mediator, which in the gastrointestinal (GI) tract, plays a 
physiological role in gut-brain signaling and which is dysregulated in functional GI disorders 
such as irritable bowel syndrome (IBS). Patients suffering from IBS frequently suffer from 
urological symptoms characteristic of interstitial cystitis/painful bladder syndrome, which 
manifests due to cross-sensitization of shared innervation pathways between the bladder 
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and colon. However, a direct modulatory role of 5-HT in bladder afferent signaling and its 
role in colon-bladder neuronal crosstalk remain elusive. The aim of this study was to 
investigate the action of 5-HT on bladder afferent signaling in normal mice and mice with 
chronic visceral hypersensitivity (CVH) following trinitrobenzenesulfonic acid (TNBS) induced 
colitis. Bladder afferent activity was recorded directly using ex vivo afferent nerve recordings. 
Expression of 14 5-HT receptor subtypes, the serotonin transporter (SERT) and 5-HT 
producing enzymes were determined in the urothelium using RT-PCR. Retrograde labelling 
of bladder projecting dorsal root ganglion (DRG) neurons was used to investigate expression 
of 5-HT3 receptors using single cell RT-PCR, while sensory neuronal and urothelial 
responses to 5-HT were determined by live cell calcium imaging. 5-HT elicited bladder 
afferent firing predominantly via 5-HT3 receptors expressed on afferent terminals. CVH 
animals showed a downregulation of SERT mRNA expression in urothelium, suggesting 
increased 5-HT bioavailability. Granisetron, a 5-HT3 antagonist, reversed bladder afferent 
hypersensitivity in CVH mice. These data suggest 5-HT exerts a direct effect on bladder 
afferents to enhance signaling.5-HT3 antagonists could therefore be a potential therapeutic 
target to treat functional bladder and bowel disorders.          
Introduction  
Information regarding the state of bladder distension is carried via sensory afferents that 
project via the pelvic and hypogastric nerves into the dorsal horn of the spinal cord, feeding 
into autonomic reflex and micturition centers within the brainstem to maintain continence 
(see Grundy et al. 2018a for review). Bladder afferents are found innervating both the 
detrusor smooth muscle and the urothelium (Spencer et al., 2018), consisting of myelinated 
Aδ fibres and unmyelinated C fibres that exhibit polymodal sensitivity to a host of mechanical 
and chemical stimuli (Su and Gebhart, 1998; Zagorodnyuk et al., 2006; Zagorodnyuk et al., 
2007). Hypersensitivity of these bladder afferents to bladder distension may underlie the 
symptoms of urgency, frequency and nocturia in urological disorders such as overactive 
bladder syndrome (OAB) and interstitial cystitis/painful bladder syndrome (IC/PBS).   
Serotonin (5-HT) is a key neuromodulator, regulating enteric and viscerosensory function as 
well as acting in the central nervous system (Berger et al., 2009; Gershon and Tack, 2007; 
Grundy, 2008). Out of the seven members of the 5-HT receptor family (5-HT1-7), six are G-
protein coupled receptors (GPCRs) and one,  the 5-HT3 receptor is a ligand-gated ion 
channel (McCorvy and Roth, 2015). Within the bladder, activation of 5-HT1A, 5-HT 2 and 5-
HT3, but not 5-HT4 and 5-HT7 can generate altered bladder contraction in rodent models 
(Chetty et al., 2007; Kodama and Takimoto, 2000; Mittra et al., 2007). 5-HT3A and 5-HT3B are 
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expressed in the bladder urothelial layer and detrusor, where it is considered to play a role in 
neurogenic contraction (Chetty et al. 2007), whilst 5-HT receptor subtypes 5-HT1D, 2A, 4 and 
5-HT6 are present in urothelial cells. 5-HT1A, 1B, 1D, 2A, 2B, 2C, 3A, 4, and 5-HT7 have also been 
reported in urothelium-denuded tissues (Matsumoto-Miyai et al., 2016). However, a 
modulatory role of 5-HT on bladder afferent excitability has yet to be explored. 
Significant clinical comorbidity exists between a number of lower urinary tract and colonic 
disorders, such that the symptoms of bladder dysfunction, including urinary frequency, 
urgency, and pelvic pain are significantly more common amongst IBS patients than in control 
groups (Daly and Chapple, 2013; Grundy and Brierley, 2018). Additionally, one-third of IC 
patients exhibit concurrent IBS symptoms including abdominal pain, discomfort, constipation 
and/or diarrhea (Aaron and Buchwald, 2001). The origin of these clinical co-morbidities is 
embedded within the physiological coordination of pelvic organs to provide efficient and 
synchronized defecation and micturition responses, and their shared innervation pathways 
within the DRG and spinal cord (Grundy et al., 2019). As such, sensitization of the afferents 
innervating one pelvic organ, has the potential to sensitize adjacent organs via cross-organ 
sensitization (Brumovsky and Gebhart, 2010; Christianson et al., 2007; Grundy et al., 2018b; 
Malykhina, 2007) .  
2,4,6-trinitrobenzene sulfonic acid (TNBS) induced colitis is a commonly used animal model 
of IBS, triggering chronic visceral hypersensitivity (CVH) that persists after the initial 
inflammation has resolved (Castro et al., 2017; de Araujo et al., 2014; Hughes et al., 2009; 
Osteen et al., 2016). Furthermore, it has been shown that these CVH mice exhibit bladder 
afferent hypersensitivity and abnormal voiding patterns, characteristic of an ‘overactive’ 
phenotype (Grundy et al., 2018b). 5HT plays an essential role in health and the development 
of colonic afferent hypersensitivity associated with irritable bowel syndrome (IBS) in humans 
(Gershon and Tack, 2007; Grundy, 2008) and animal models (Keating et al., 2008; Linden et 
al., 2003; Linden et al., 2005). As such, this raises the possibility that bladder hypersensitivity 
associated with TNBS-induced colitis may involve a 5-HT3 receptor dependent mechanism.  
Therefore, we performed bladder afferent recordings to investigate the modulatory action of 
5-HT on primary afferent signaling in mouse urinary bladder and in a TNBS-induced colitis 
model of colon-bladder neuronal ‘cross talk’. We also used calcium imaging and single cell 
RT-PCR of retrogradely traced bladder-innervating afferent dosral root ganglion (DRG) 
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Methods 
Ethical approval  
Most of the experiments in this study were conducted at the university of Sheffield in the 
United Kingdom, in accordance with the University of Sheffield's Animal Care Committee, 
under an approved UK protocol and project license. A small number of experiments including 
the induction of TNBS, retrograde tracing studies and dorsal root ganglion (DRG)  
experiments (calcium imaging and single cell RT-PCR) were performed in Adelaide, 
Australia. Experiments performed in Australia were approved by and performed in 
accordance with the Animal Ethics Committees of the South Australian Health and Medical 
Research Institute (SAHMRI; Application # SAM190, SAM195, and SAM281). 
Animals 
All experiments performed in the UK used C57/BL6 adult male mice (12-16 weeks old, 25-30 
g) from Charles River (Margate, UK). The animals were acclimatized for 7 days in the 
laboratory animal husbandry unit under 12-hr light/ 12-hr dark cycle and had free access to 
water and food. The animals were anaesthetized with isoflurane and humanely sacrificed by 
cervical dislocation according to UK home office legislation (Scientific procedure Act 1986) 
and in compliance with Journal of Physiology’s ethical guidelines (Grundy, 2015).  
For Experiments performed in Australia 12-16 week male and female mice were acquired 
from an in-house C57BL/6J breeding program (JAX strain #000664; originally purchased 
from The Jackson Laboratory; breeding barn MP14; Bar Harbor, ME) within SAHMRI’s 
specific and opportunistic pathogen-free animal care facility. Mice were group housed (5 
mice per cage) in specific housing rooms within a temperature-controlled environment of 
22°C and a 12-hr light/ 12-hr dark cycle. Mice had free access to food and water.  
2,4,6-trinitrobenzenesulfonic acid (TNBS) treatment  
13-week old anesthetized male mice were intracolonically administered with 2,4,6-
trinitrobenzenesulfonic acid (TNBS) 0.01 mL (130 µg mL-1 in 30% ethanol) via a 
polyethylene catheter to induce colonic inflammation. Histological examination of colon and 
bladder was performed to monitor mucosal architecture and signs of inflammation, i.e., 
cellular infiltration, crypts abscesses, and goblet cell depletion (data not shown). In this study 
we investigated the effect of TNBS colitis at 2 time points; acute TNBS (3 days post-
treatment) when there is an active inflammatory state (termed acute visceral hyposensitivity, 
‘AVH’) and 28 days post-treatment, when the inflammation has resolved but the bladder 
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afferent hypersensitivity still persist (termed chronic visceral hypersensitivity, ‘CVH’). For ex 
vivo experiments mice were humanly sacrificed by cervical dislocation.  
 
Extracellular afferent nerve recordings 
Bladder afferent nerve activity was determined using an ex vivo model previously described 
(Daly et al., 2007; Grundy et al., 2018a). The whole bladder and surrounding tissues 
(together with its emanating nerve fibers) was placed in a recording chamber (30 mL). The 
preparation was continuously perfused at a rate of 5 mL minute-1 with oxygenated 
(95%O2/5%CO2) Krebs bicarbonate solution (composition, mM: NaCl 118.4,
 NaHCO3 24.9, 
CaCl2 1.9, MgSO4 1.2, KCl 4.7, KH2PO4 1.2, glucose 11.7) at constant temperature of 35 °C. 
A polythene catheter (0.28 mm) was inserted into the urethra to perfuse the bladder with 
isotonic saline (0.9% NaCl) or pharmacological reagents using a perfusion pump (Genie, 
Kent, multi-phaser TM model NE-1000) with a rate 100 µL minute-1. The bladder dome was 
punctured at the apex with a syringe needle (BD microlanceTM, 19G 2”) and a dual-lumen 
catheter was inserted and secured with suture.One arm of the catheter was connected to a 
pressure transducer (DTXTM plus DT-XX, Becton Dickinson, Singapore) to monitor 
intravesical pressure and the other arm was connected to the 3 way tap to allow bladder 
filling (tap closed) or emptying (tap open).Multiunit pelvic and hypogastric nerves were 
dissected into a fine branches and placed into a suction electrode which was attached to a 
Neurolog headstage (NL 100, Digitimer, Ltd, UK), amplified with an AC amplifier (NL104) 
and filtered (NL125, band pass filter. The multi-unit afferent nerve discharge frequency 
(spikes/sec) was quantified using a spike processor (Digitimer D130). The signal was 
visualized on a computer running Spike 2 software (Version 7.1, Cambridge Electronic 
Design, UK).  
Drug application  
After a 30-minute stabilization period the bladder was distended by an intravesical infusion 
with saline at a rate of 100 µL minute-1 to a maximal pressure 50 mmHg (control 
distensions). This was repeated at 10-minute intervals for 30-60 minutes to establish 
reproducible afferent responses before starting the protocol. After the control distensions, 
pharmacological agents were either perfused into the bladder lumen (intravesical 
application) or into the recording chamber (bath application). Following application of any 
compound a ‘wash out’ was conducted using either saline (intravesical) or Krebs (bath 
application) as appropriate for 30 minutes.  
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Isovolumetric protocol 
In order to evaluate the effect of a pharmacological reagents on spontaneous afferent firing 
and bladder tone, isovolumetric experiments were conducted. After a 30-60 minute 
stabilization period the bladder was filled to an intravesical pressure of 15 mmHg and left to 
stabilize for 30 minutes to allow the bladder to accommodate to the intravesical volume 
before bath application of agonists or antagonists. Nerve firing and bladder tone were 
continuously captured. Bladder contraction was determined as an increase in intravesical 
pressure.  
 
Isolation of urothelial cells  
Urothelial cells were isolated as previously described (Daly et al., 2014). The bladder was 
dissected longitudinally under a stereo microscope to expose the urothelium to the media 
(fresh Modified Eagle Media (MEM) (Gibco®) containing 0.7% HEPES and 1% antibiotic-
antimycotic (PSF) solution (Gibco®) at 37°C and transferred to a Sylgard® (Dow Corning) 
coated dish. The tissue was stretched and pinned. The media was removed and replaced 
with 2.5 mg/mL dispase in MEM at 37°C. The bladder was incubated in dispase for 2 hours 
at room temperature. After the dispase had been aspirated, the urothelium was gently 
scraped with a scalpel under the stereo microscope and the cells were immediately placed in 
0.5% trypsin-EDTA (Gibco®). The solution was incubated at 37 °C for 10 minutes, and gently 
triturated every a few minutes. The trypsin-EDTA was deactivated by adding pre-warm MEM 
with 10 % Fetal Bovine Serum (FBS) (Gibco®). The cell suspension was centrifuged at 1500 
rpm, 4 °C for 15 minutes. The solution was gently aspirated and the pellet was resuspended 
in pre-warmed Keratinocyte-serum free medium (K-SFM) and centrifuged at 1500 rpm, 4 °C 
for 15 minutes. For calcium imaging experiment, the cells were resuspended in K-SFM 200 
µL and plated on collagen IV (Sigma Aldrich Poole, UK) coated coverslips in a 12 wells plate 
and incubated in 5% CO2-95% O2 at 37 °C overnight. For PCR experiments, the cell pellet 
was washed by adding PBS and centrifuged at 1000 rpm, 4 °C for 5 minutes and stored at -
80 °C for RNA isolation process. 
 
Reverse-transcription PCR (RT-PCR) 
Urothelial cell pellets were used in this experiment. The total RNA was extracted using an 
RNeasy mini Kit (Qiagen, Valencia, CA, USA. RNA was transcribed to cDNA by High 
Capacity cDNA Reverse Transcription Kit with RNase Inhibitor (Applied Biosystems, 
Carlsbad, CA, USA).PCR reactions were prepared using Gotaq® Green Master Mix 
(Promega M7121) according to manufacturer’s instructions (Total volume 25 µL; Gotaq 
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Gotaq® Green Master Mix 12.5 µL, forward and reward primers 2.5 µL, cDNA for 50 ng 
RNA, nuclease-free water was adjusted to volume 25 µL). The samples were run in 
triplicate. The list of exon spanning primers used is summarised in Table 1. ß-actin was used 
as a house keeping gene and either brain, DRG neurons, or duodenum was used as positive 
control. For negative control reactions, distilled water was used instead of cDNA samples. All 
the PCR products of detected 5-HT receptors were checked by DNA sequencing and all 
genes showed a high percentage matching (96-100%) to the original sequences, suggesting 
that the designed primers were efficient and the detected 5-HT receptor results were valid 
(data not shown). 
Retrograde tracing of bladder innervating DRG neurons 
A small aseptic abdominal incision was made in anesthetised (isoflurane 2-4 % in oxygen) 
mice. Cholera toxin subunit B conjugated to AlexaFluor® 488 (CTB-488; 0.5 % diluted in 0.1 
M phosphate buffered saline (PBS); ThermoFisher Scientific) was injected at four sites into 
the bladder wall (2µL / injection) using a 5 µl Hamilton syringe attached to a 23-gauge 
needle. The abdominal incision was sutured closed and analgesic (Buprenorphine; 2.7µg / 
30g) and antibiotic (Ampicillin; 50 mg/kg) given subcutaneously as mice regained 
consciousness. Mice were allowed to recover, housed individually and monitored for four 
days, in order to visualize CTB-labelled afferent neurons in the DRG. 
Isolation of DRG neurons  
DRGs from lumbosacral (L5-S1) spinal levels of the mouse spinal cord, which correspond to 
the pelvic innervation of the bladder, were isolated and incubated in Hanks balanced salt 
solution (HBSS) (pH 7.4) containing collagenase (4mg/mL), and dispase (4.5mg/mL), at 
37°C for 30 minutes. The collagenase/dispase solution was aspirated and replaced with 
HBSS containing collagenase (4mg/mL) for 10 minutes at 37°C. The collagenase solution 
was aspirated and replaced with 600µl DMEM (GIBCO) containing 10% FCS (Invitrogen), 
2 mM L-glutamine (GIBCO), 100 μM MEM non-essential amino acids (GIBCO) and 
100 mg/ml penicillin/streptomycin (Invitrogen). Neurons were dissociated via trituration with a 
Pasteur pipette and spot plated onto 15 mm coverslips coated with laminin (20 μg/mL) and 
poly-D-lysine (800 μg/ mL) and maintained in an incubator at 37 °C in 5% CO2. Calcium 
imaging recordings were performed on DRG neurons 18-30hrs post isolation.  
Single cell RT-PCR  
Cells were used 3-8 hrs after plating a cover slips. Under continuous perfusion of sterile and 
RNA-/DNase-free PBS, retrogradely traced single DRG neurons (N=3/group; HC: total 77 
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cells, CVH: total 74 cells; 23-27 cells per mouse) were identified using a fluorescent 
microscope and picked using a micromanipulator into the end of a fine glass capillary. The 
glass capillary containing the cell was then broken into a sterile Eppendorf tube containing 
10 L of lysis buffer with 1µl DNAse (TaqMan Gene Expression Cells-to-CT Kit; Life 
Technologies). Samples were treated according to manufacturer’s instructions for cDNA 
synthesis using SuperScript™ VILO™ cDNA Synthesis Kit (ThermoFisher Scientific) and 
RT-PCR using TaqMan™ Universal Master Mix (ThermoFisher Scientific). Ready-made 
TaqMan probes were purchased from LifeTechnologies (Htr3a: Mm00442874_m1). For each 
coverslip of cells, a bath control was also taken and analysed together with cells. A total of 
45 cycles was run and only samples with a complete amplification curve were considered as 
positive. After lysis and termination of DNAse treatment, samples were immediately frozen 
on dry ice and stored at -80C until cDNA synthesis was performed. Tubulin-3 expression 
(Mm00727586_m1) served as a neuronal marker and positive control and for every coverslip 
a bath control was taken and analysed together with other samples. GFAP expression 
(Mm01253033_m1) was measured to exclude contamination with glial cells. PCR products 
were stored at -20C and resolved on a 3-4% TBE agarose gel (UltraPure Agarose 1000, 
cat#16550-100, Invitrogen). All samples were visualized by adding 1µl of Midori Green 
Direct (NIPPON Genetics) to 20µl of sample and 5µl of samples was loaded onto wells. A 
20bp marker (BioRad) was used to check for correct size.  
Quantitative real-time RT-PCR 
To determine the quantitative expression of TPH1 2 and SERT in urothelial cell samples 
from sham and TNBS treated animals, quantitative RT-PCR was used. The quantification of 
mRNA expression determined using TaqMan Gene Expression Master Mix (Applied 
Biosystems 4374657). The reaction was prepared on ice and mixed in Hard-Shell® Thin-
Wall 96-Well Skirted PCR Plates (BIO-RAD, HSP-9665). Prior to running the reactions, the 
plates were covered with MicroAmpTM Optical Adhesive Film for 96-Well Plates (Applied 
Biosystems, 43111971) and centrifuged briefly to spin down the contents and eliminate any 
air bubbles from the solutions. The reaction for each sample and gene was run in duplicate. 
DNase free water was used to replace cDNA as a negative control for each gene and plate. 
PCR reactions were performed in a BIO-RAD CFX96 TouchTM Real-time thermocycler 
(C1000 TouchTM Thermal Cycler, Bio-Rad Laboratories Ltd. Hercules, USA). Results were 
expressed as relative expression to the housekeeping gene GAPDH (1/ΔCt), and fold 
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Calcium imaging 
Cultured DRG neurons (18-30 hours) or isolated urothelial cells were loaded with 2 μM fura-
2-acetoxymethyl ester (Fura-2) for 15 minutes at 37°C and washed with HEPES buffer 
(10mM, NaCl 142mM, KCl 2mM, glucose 10mM, CaCl2 2mM, MgCl2 1mM, HEPES 10mM; 
pH 7.4) for 30 minutes prior to imaging at room temperature (23°C). Fura-2 was excited at 
340 and 380 nm. Fluorescence images were obtained every 5s using a 20x objective. 
Retrogradely traced bladder-innervating DRG neurons were identified by the presence of the 
CTB-488 tracer. Data were recorded and analysed using MetaFluor software. After an initial 
baseline reading to ensure cell fluorescence was stable (an indication of healthy cells), 
DRGs and/or urothelial cells were stimulated with either 5-HT (100 µM), 2-Me-5HT (100 
µM)in the absence or presence of granisetron (1 µM), and changes in intracellular calcium 
[Ca2+]i, were monitored in real-time. Ionomycin or KCl (40 mM) was applied as a positive 
control for cell viability.   
Drugs and solutions 
5-hydroxytryptamine (5-HT) and 5-methoxytryptamine (5-MT) were obtained from Sigma 
Aldrich, UK. 2-Methy5-hydroxytrptamine (2-Me-5-HT) was obtained from Tocris/Bioscience, 
UK. Granisetron hydrochoride was obtained from LKT Laboratories, USA. ML-9 was 
obtained from Cayman Chemical. Y-27632 was obtained from Chemdea, USA.  
 
Data analysis  
Spontaneous afferent firing (also referred to as baseline) was determined by measuring 
mean action potential firing rate over 10 seconds either at rest (before a drug application or 
before a distension). This is defined as the afferent activity arising from the bladder in the 
absence of a stimuli (mechanical or chemical). Mechanosensitive afferent firing was 
determined by performing ramp distension of the bladder (as described above) and 
measuring the afferent discharge at various intravesical pressure points using a custom-built 
script from SPIKE 2 version 7 (CED, UK). Data are expressed as means ± SEM. Statistical 
analysis was analyzed using one- or two-way analysis of variance (ANOVA) with Dunnett’s 
or Tukey multiple comparison or Student’s t test, where appropriate. The statistical analysis 
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Results 
Intravesical administration of 5-HT agonists excites bladder afferent nerves 
In order to determine if bladder afferents functionally express 5-HT receptors, we 
investigated the effects of various 5-HT receptor agonists on ex-vivo bladder afferent nerve 
activity. We found that intravesical infusion of 5-HT (100 µM), evoked a dramatic and 
sustained increase in baseline afferent nerve firing compared to intravesical saline (Fig. 1A, 
1B). The receptor mechanisms underlying this effect were determined by comparing the 
responses to 2-Me-5-HT, a selective 5-HT3 agonist (100 µM), with 5-MT (100 µM) a 
compound which exhibits selectivity for the GPCR family of 5-HT receptors including 5-HT1, 
5-HT2 and 5-HT4-7. The responses to application of 5-HT and 2-Me-5-HT were comparable. 
However while the response to 5-MT, was significantly increased relative to baseline, the 
magnitude of the firing was reduced compared to that of 5-HT and 2-Me-5-HT (Fig. 1C, 1D). 
These data suggest that multiple 5-HT receptors may influence bladder afferent firing, and 
that this may occur via both direct and indirect mechanisms.  
5-HT receptors are expressed on bladder urothelium  
Given the established role of the urothelium as a sensory structure, we wanted to determine 
if the effects of intravesical 5-HT on bladder afferent firing were secondary to activation of 
urothelial cells or a consequence of direct activation of primary afferent endings innervating 
the bladder. To this end we investigated serotonergic receptor expression in the bladder 
urothelial layer using RT-PCR. The expression profile for the various 5-HT receptors in the 
urothelium is shown in Figure 2. Overall, 5-HT1A, 5-HT1B, 5-HT1D, 5-HT2A, 5-HT2B, 5-HT4, 5-
HT6, and 5-HT7 receptors were all detected. In contrast, 5-HT1F, 5-HT2C, 5-HT3A, 5-HT3B or 
the 5-HT5A, 5-HT5B receptors were not detected in the bladder urothelium. Moreover, 
expression of the 5-HT producing enzymes, tryptophan hydroxylase-1, and 2 (TPH-1 and 
TPH-2), and the sodium-dependent serotonin transporter (SERT) transcripts were also 
examined using PCR and all three were shown to be expressed in the urothelium (Fig. 2). 
This finding raises the possibility of an endogenous source of 5-HT in the bladder wall.  
Stimulation of non-5HT3 receptors on the urothelium can evoke urothelial cell 
activation 
Calcium imaging of isolated primary mouse urothelial cells (PMUCs) was conducted to 
investigate the functionality of 5-HT receptors in the urothelium. Incubation of PMUCs with 5-
HT triggered an increase in intracellular Ca2+ indicative of cellular activation. Consistent with 
our RT-PCR data identifying an absence of 5-HT3 receptor expression in the urothelium, 
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both the magnitude of the response to 5-HT and the number of responding cells was 
unchanged following incubation with the 5-HT3 selective antagonist granisetron (Fig. 3B, 
3C).  
Activation of 5-HT receptors by bath application of agonist alters afferent nerve firing 
from the bladder and induces contraction of the detrusor 
To elucidate if the 5-HT effects on bladder afferent activity are secondary to induced 
detrusor contraction, we applied agonists, antagonist and muscle contraction inhibitors under 
isovolumetric bladder conditions to determine their effect on spontaneous afferent firing and 
associated intravesical pressure changes. A representative trace of extraluminal 5-HT 
application on bladder afferent firing and intravesical pressure is illustrated in Fig. 4A. We 
found that 5-HT (100 µM), 2-Me-5-HT (100 µM) or 5-MT (100 µM) all evoked a marked 
increase in bladder afferent nerve firing, and a small but robust increase in intravesical 
pressure indicating detrusor contraction (Fig. 4B, 4C). 
The peak afferent response to bath application of 5-HT and 2-Me-5-HT was similar. 
Moreover, application of the selective 5-HT3 receptor antagonist, granisetron (1 µM), 
significantly attenuated afferent responses to 5-HT. To uncouple the direct effect of 5-HT on 
the afferent nerves from any indirect nerve response produced by bladder contraction we 
used a myosin light chain kinase inhibitor (ML-9, 10 µM) and/or the rho-associated kinase 
inhibitor (Y-27632, 10 µM) to prevent contraction. Under such conditions the afferent 
response to 5-MT was abolished in the absence of contraction, suggesting that the response 
to 5-MT was secondary to changes in muscle tone. Conversely, the afferent response to 2-
Me-5-HT persisted despite the absence of contraction, suggesting that the contractile and 
nerve responses to 5-HT3 receptor stimulation were independent (Fig. 4B and 4C). 
Chronic visceral hypersensitivity evoked with intra-colonic TNBS caused altered 
mechanosensitivity and increased spontaneous afferent firing from the bladder, an 
effect that was reversed by blocking the 5-HT3 receptor. 
Bladder hypersensitivity has been described in response to colonic inflammation, a 
phenomenon referred to as cross-organ sensitization. Since 5-HT is implicated in colonic 
hypersensitivity we investigated the extent to which it may contribute to altered bladder 
afferent signalling in a mouse model of TNBS-induced colonic inflammation. We examined 2 
time points representing acute inflammation (3 days post-treatment) and a chronic state in 
which inflammation had resolved (28 days post-treatment). Acute TNBS treatment had no 
significant effect on spontaneous nerve firing from the bladder and caused a moderate 
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(~25% from sham control) decrease of mechanosensitive afferent firing at 50 mmHg (Fig. 
5A). Conversely, in the post-inflammatory CVH state there was a significant increase in 
spontaneous bladder afferent firing (~160%) and in the afferent response to bladder 
distension (~27%) when compared to sham controls (*P<0.05, Fig 5). Treatment with 
granisetron (1 µM) prior to 5-HT application normalized both the spontaneous bladder 
discharge and the mechanosensitivity observed in the CVH model (Fig. 5A, 5B).  
SERT mRNA expression was downregulated in urothelial cells of CVH mice. 
The attenuated responses in the presence of granisetron implies a role for endogenous 5-HT 
in bladder hypersensitivity. We hypothesized that there might be a change in 5-HT 
bioavailability in the urothelium following chronic visceral hypersensitivity (CVH) induced by 
intra-colonic TNBS. Quantitative RT-PCR showed that the level of SERT mRNA expression 
was significantly lower in urothelial cells from bladders in TNBS treated mice compared to 
sham operated controls (*P<0.05, Fig. 6A). TPH1 and TPH2 mRNA expression was also 
reduced, but because of the large variability, especially in TPH1 levels, this did not reach 
significance (Fig. 6B, 6C). Nevertheless, these data are consistent with a role for urothelial 
5-HT in bladder hypersensitivity.  
Bladder projecting DRG neurons express 5-HT3 receptors in both control and CVH 
mice and display functional response to 5-HT and 2-Me-5-HT activation.  
To examine if 5-HT3 receptors in the afferent terminals play a role in 5-HT-senstitized 
bladder afferent firing, we performed retrograde labelling and single cell RT-PCR to examine 
5-HT3 receptor gene expression in bladder-projecting DRG neurons. The vast majority of 
these neurons (91%, 70/77 neurons) expressed 5-HT3 receptors even in control animals, 
which is striking given the absence of any previously documented endogenous source of 5-
HT. Moreover, 95% of bladder-innervating DRG isolated from mice with CVH expressed 5-
HT3 (70/74 neurons), showing a small increase in the number of neurons expressing 5-HT3 
occurs during cross-organ sensitization. (Fig. 7A).  
In addition, we performed calcium imaging on bladder innervating (traced) and non-traced 
lumbosacral DRG neurons. A representative trace of calcium imaging of lumbosacral DRG 
neurons in response to 5-HT (100 µM) and 2-Me-5-HT (100 µM) is shown in Figure 7B. 60 
out of a total of 69 (87%) bladder projecting DRG neurons (traced neurons) elicited a 
calcium signal in response to application of 5-HT, moreover a significantly greater proportion 
of the traced DRGs responded to 5HT than the non-traced DRG neurons. This indicates that 
expression of 5-HT receptors maybe enriched in bladder neurons compared to the 
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generalized neuronal population. In addition, a similar proportion of traced neurons (70%, 
36/51) showed an increase in Ca2+ influx after the application of 2-Me-5-HT (Fig. 7C). The 
magnitude of the Ca2+ response to 5-HT and 2-Me-5-HT was similar in traced and non-
traced DRG neurons (Fig. 7D). These data are consistent with a major contribution of 5-HT3 
receptors to 5-HT’s ability to sensitize bladder afferents and enhance firing.     
Discussion  
Over the past decade, a number of studies, including our own, have investigated the 
chemical and mechanical stimuli that drive afferent transmission from the bladder. Despite 
this, the mechanisms involved in generating bladder hypersensitivity still remain elusive. 
There is significant clinical comorbidity between hypersensitivity disorders of the bladder and 
hypersensitivity disorders of the colon (such as IBS), pointing to a common underlying 
etiology involving dichotomizing afferent fibres between the bladder and bowel (Grundy and 
Brierley, 2018; Malykhina, 2007).  Serotonin (5-HT) plays integral roles in secretion, motility 
and visceral sensitivity of the GI tract (Grundy, 2008). However, relatively little is known 
about how 5HT affects afferent signaling from the bladder in healthy or hypersensitivity 
states. In this study we investigated the modulatory action of 5-HT on primary afferent 
signaling in the mouse urinary bladder and in a TNBS-induced model of colitis which induces 
colon-bladder cross-organ sensitization (Grundy et al., 2018b). 
5-HT increases bladder afferent firing and induces contraction of the detrusor  
Stimulation of 5-HT receptors with serotonin caused a large increase in bladder afferent 
nerve firing, which was concomitant with a small but significant contraction of the bladder. 
When the contraction was blocked using a combination of muscle blockers the sensory 
response was significantly attenuated. This suggests that a proportion of the afferent 
response to 5-HT occurred via the activation of mechanosensory afferent nerves which were 
activated in response to bladder contraction. However, since the afferent response to 5-HT 
was only partially reduced, it is also likely that there was also an additional direct mechanism 
by which 5-HT stimulated a receptor(s) on the nerve terminal,  inducing nerve firing in a 
mechanism that was independent from changes in the muscle tone.  
Similar to 5-HT, bath application of the selective 5-HT1, 5-HT2, 5-HT4, 5-HT6, and 5-HT7 
agonist, 5 methoxy tryptamine (5-MT) also caused an increase in afferent nerve firing and 
evoked a small contraction of the bladder. However, when the contraction was blocked by 
preincubation with the muscle blockers (Y-27632 and ML-9), the contraction was lost and the 
afferent response to 5MT was abolished suggesting that the afferent response to stimulation 
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of the non-5HT3 receptor populations was secondary to changes in bladder contraction 
rather than via a direct action at the afferent terminal. A number of previous studies have 
demonstrated that 5-HT can induce contraction of bladder muscle strips in vitro, however the 
receptor that mediates the contraction remains controversial. Hattori et al., (2017) show that 
both 5-HT and a selective 5-HT2 receptor agonist cause contraction of the bladder, but a 
lack of efficacy following pre-incubation of selective 5-HT2 receptor antagonists suggested 
that the effect was not mediated by the 5-HT2 receptor (Hattori et al., 2017). In another study 
it was shown that 5-HT potentiates neurogenic contractions of rat isolated detrusor muscle 
through both 5-HT7 and 5-HT2c receptors (Rekik et al., 2011). Moreover, in the guinea pig 
the contractile response to 5-HT was suggested to be via the 5-HT2, 5-HT3 and 5-HT4 
receptors (Yoshida et al., 2002). 
5-HT has a direct effect on afferent firing via the 5-HT3 receptor 
Bath application of 2-Me-5-HT caused a robust increase in nerve firing that was not affected 
by blocking contractility. 2-Me-5-HT is a potent agonist of both the 5-HT3 and the 5-HT6 
receptor (Glennon et al., 2000) suggesting that activation of either 5-HT3 or 5-HT6  located on 
the urothelium (in the case of 5HT6) or at the nerve terminal results in afferent nerve firing 
from the bladder. Since we did not use a selective 5HT6 receptor antagonist we cannot 
determine from these data what contribution 5HT6 made to the 2-Me-5-HT response. Since 
the role of 5HT6 in the lower urinary tract is relativity understudied this would warrant further 
investigation. However in this study we focused on the 5-HT3 receptor since pre-incubation 
of the 5-HT3 selective antagonist granisteron inhibited the 5-HT-mediated increase in 
bladder afferent nerve firing by ~65%.  Since 5-HT3 receptors were not identified in the 
urothelium via RT-PCR, this suggests that stimulation of 5-HT3 receptors can elicit a direct 
increase in afferent nerve firing by stimulating receptors on the nerve terminal rather than via 
an indirect mechanism as a result of muscle contraction or urothelial signaling. Our 
retrograde tracing studies revealed that the majority of lumbosacral DRG neurons 
innervating the mouse urinary bladder (90%) express the 5-HT3 receptor. Furthermore, our 
functional calcium imaging showed that the majority of these DRGs exhibit functional 
responses to 5-HT (87%) and the 5-HT3 selective agonist, 2-Me-5-HT (70%). In this study 
we did not stain the afferent terminals and show expression of 5HT3 in bladder afferent 
endings, although it is well established that expression in the cell body where the receptor is 
synthesized is likely to be indicative of expression at the afferent terminal. Therefore these 
data suggest that 5-HT exerts a direct action on 5-HT3 receptor at the terminal endings of 
the primary afferents innervating the bladder. This idea is supported by previous studies 
which show that 5-HT3 receptors are also located in rat DRG neurons (Nicholson et al., 
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2003) and that systemic injection of a 5-HT precursor (5-hydroxytryptophan, 5-HTP), triggers 
bladder hyper-excitability in a mechanism mediated by spinal 5-HT3 receptors (Hall et al., 
2015).  
 A recent study has also shown that bladder-projecting neurons in the caudal raphe nucleus, 
the area of the brainstem which exhibits supraspinal control of the bladder, also express 
serotonin (Ahn et al., 2018), suggesting that serotonergic control of the bladder could have 
both peripheral and central components which involve the 5-HT3 receptor. 
5-HT can alter signaling in the urothelium in a mechanism that is independent of the 
5-HT3 receptor 
Over the past decade it has become increasingly clear that the urothelium of the bladder 
plays an active role in sensation. It is responsive to bladder filling and releases an array of 
mediators and neurotransmitters which target underlying afferent nerves to modulate firing 
(urothelial- afferent signaling). Since 5-HT receptor agonists altered sensory signaling from 
the bladder we wanted to determine what role the urothelium played in the afferent 
response. mRNA for  5-HT1A, 5-HT1B, 5-HT1D, 5-HT2A, 5-HT2B, 5-HT4, 5-HT6, and 5-HT7 
receptors were identified in the urothelium and our functional calcium imaging experiments 
demonstrated that ~60% of isolated primary urothelial cells were activated by stimulation 
with 5-HT. This indicates that there may be functional 5-HT receptors in the urothelium that 
could play a role in both autocrine urothelial mechanisms and paracrine sensory 
mechanisms. It is important to note that we did not conduct any western blot analysis or 
immunocytochemistry to confirm the protein expression of these receptors in the urothelium, 
nor did we use an array of selective agonist and antagonists in the calcium imaging 
experiments, this makes it difficult for us to identify which receptor(s) mediate the calcium 
responses. However, pretreatment with the 5-HT3 selective antagonist, granisetron had no 
effect on the magnitude of the calcium signals or on the numbers of responsive cells. This 
taken together with the fact that mRNA for the 5-HT3 receptor was not identified in the 
urothelium suggests that while the 5-HT3 receptor may be involved in the direct afferent 
response to 5HT (i.e. at the 5-HT3 receptor on the primary afferent terminal) it is not involved 
in urothelial signaling. Further studies are required to delineate the differential role that non-
5HT3 receptors play in mediating contractility and urothelial signaling in the bladder.  
5-HT3 receptor mechanisms contribute to bladder hypersensitivity in CVH.  
Christianson et al., (2007) demonstrated that 21% of all retrograde traced mouse DRGs from 
the colon also  innervated the bladder (dichotomizing neurons) (Christianson et al., 2007).  
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Since co-morbidities between the bladder and bowel are common, the hypothesis of ‘cross-
organ sensitization’ has emerged. Evidence for this phenomenon has come from pre-clinical 
studies identifying that inflammation or injury to one organ, such as the bowel, can lead to 
changes in the sensitivity of another closely located organ, such as the bladder, via these 
convergent neural pathways. A number of models of colon-bladder cross organ sensitization 
have been developed to study this phenomenon, one such model is the well-established 
TNBS model of colitis (Antoniou et al., 2016; Grundy et al., 2018b; Malykhina et al., 2006; 
Qin et al., 2005) . Previous studies using the TNBS induced colitis model suggest that 
inflammation of the bowel induces hypersensitivity of colonic afferents and changes in spinal 
neural circuitry that persists after the inflammation as resolved (Brierley and Linden, 2014). 
This effect is concomitant with hypersensitivity of the bladder and bladder voiding 
dysfunction indicative of overactive bladder syndrome or painful bladder syndrome, without 
any obvious morphological changes in bladder structure. Two phases of response have 
been identified; an acute phase of visceral hyposensitivity (AVH, <15 days post treatment) 
and a chronic phase of visceral hypersensitivity (CVH, >28 days post treatment) (Grundy et 
al., 2018b). 
The 5HT3 receptor has been linked to intestinal dysfunction in a number of studies. For 
example, the selective 5-HT3 antagonists tropisetron and ondansetron significantly reduce 
signs of inflammatory damage in the bowel in a TNBS-induced colitis model in the rat 
(Motavallian-Naeini et al., 2012; Motavallian et al., 2013). Bioavailability of 5-HT in the 
bowel, as measured by expression of the serotonin reuptake transporter (SERT), is reduced 
in mice (Linden et al., 2005), guinea pigs (Linden et al., 2003) and humans with either 
inflammatory conditions of the bowel or irritable bowel syndrome (Coates et al., 2004). In 
addition, in a Trichinella spiralis  induced model of post-infectious IBS, long-term 
hypersensitivity of the small intestine was shown to be mediated by changes in 5-HT3 
receptor expression (Keating et al., 2008). 
In the present study, after the induction of colitis with TNBS, the afferent response to bladder 
distension was actually inhibited by ~20%, suggesting hyposensitivity of the bladder afferent 
nerves in the acute phase colitis. However, in the post-inflammatory pahse of CVH, the 
afferent response to bladder distension was significantly increased. This is consistent with 
previous data (Grundy et al., 2018b), and suggests that there was long-term hypersensitivity 
of bladder afferents following inflammation of the bowel. Interestingly, the distension-induced 
hypersensitivity was attenuated via pretreatment with the 5-HT3 selective antagonist 
granisetron, implicating the 5-HT3 receptor in the response. The numbers of bladder-
projecting DRG neurons expressing 5-HT3 was also slightly elevated in the CVH phase. 
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Interestingly, mRNA for the 5-HT producing enzymes, TPH1 and TPH2, and the serotonin 
transporter, SERT was detected in the normal urothelium and in the urothelium of mice 
following TNBS. However, in the urothelium of CVH mice we observed a significant 
decrease in SERT expression, which may suggest that following colonic inflammation there 
were alterations in the bioavailability of 5-HT. This could potentially lead to reciprocal 
changes in 5-HT3 receptor sensitivity and bladder afferent hypersensitivity.  
 
What is the endogenous source of 5-HT in the bladder?  
The majority of 5-HT is the body is produced by enterochromaffin cells in the GI tract 
(Gershon and Tack, 2007) and in the CNS. Activation of enterochromaffin cells can lead to 
the release of 5-HT and activation of 5-HT3 receptors on colonic afferents innervating the 
colonic mucosa (Bellono et al., 2017). In addition, mast cells also synthesize 5-HT from 5-
hydroxytryptophan and express TPH1 in the rat and human gastrointestinal tracts (Dwyer et 
al., 2016; Weitzman et al., 1985). However, the endogenous source of 5-HT in the bladder 
has yet to be identified. Since the components needed to produce 5-HT are present in the 
urothelium (ie TPH1 and TPH2  mRNA), it is possible that urothelial cells produce and 
release 5-HT which can then exert actions on afferent nerve fibers located in close proximity, 
or the underlying smooth muscle. Despite the presence of the molecular architecture 
responsible for 5-HT synthesis we identified within the urothelium, there have been no 
previous reports of 5HT release from the bladder in the literature to support this idea. 
(Fitzgerald et al. (2013) showed that there was a significant increase in the number of mast 
cells in the bladder at 12 days after colonic TNBS administration in rats, raising the 
possibility that in the post-inflammatory state, 5-HT levels in the bladder rise due to 
infiltration of circulating mast cells (Fitzgerald et al., 2013). This mechanism could drive 
altered sensory activity via an interaction with the 5-HT3 receptor on the primary afferents. 
Unfortunately, since we did not measure 5-HT levels or mast cell numbers in the bladders 
from our CVH mice this remains speculative. 
Recent studies have demonstrated the presence of 5-HT positive paraneurons in the mouse 
urethra which have a close association with urethral afferent nerves (Kullmann et al., 2018). 
In our extracellular recordings the primary afferents we recorded from lie in close proximity to 
the bladder neck. Early work by Gabella and Davis demonstrated that the majority of afferent 
innervation to the bladder lies in the lower 1/3 of the bladder body (Gabella and Davis, 
1998). Since our electrophysiological recordings consist of multi-unit nerve bundles it is 
possible that some of the afferents that we recorded from emanated from the bladder neck 
and urethra. Moreover, it is also possible that the urethral paraneurons could provide an 
endogenous source of 5-HT, which when released in the urethra either ‘diffuses’ to reach 
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some of the bladder projecting afferents or via the urethral urothelium alters urothelial- 
afferent signaling in the bladder body. A recent in vivo study lends support to this idea 
showing that 5-HT released by the urothelial cells located in the urethra can actually activate 
a urethra-vesical pathway to enhance contraction of the bladder (Coelho et al., 2018). This is 
a fascinating area for further research and further highlights the complexity of signaling in the 
lower urinary tract.  
 
Translational Perspectives 
These data suggest that 5-HT plays a key role in the modulation of bladder sensory firing 
and the generation of visceral hypersensitivity. This may have important implications for 
understanding normal function of the bladder and the changes in bladder function that arise 
when serotonergic signaling is disrupted, such that occurs in IBS or with depression and 
anxiety.  
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5-HT1A  NM_008308 FW:   5’ TAAGAACTTCCCGCTCCAGT 3’ 103 Brain 
  RW: 5’ AGAAATGCAAGGGGATCTCC 3’   
5-HT1B  NM_010482 FW: 5’ CCAACACACAATAAATGCTCCT3’ 135  DRG 
    RW: 5’ CCAAGTCAAAGTGCGAGTCT 3’     
5-HT1D  NM_008309 FW: 5’TACAAACACCCCTACTAAACGC 3’ 310 DRG  
    RW: 5’ATGAGTGTTCAGCGTTGGTT 3’     
5-HT1F NM_008310 FW: 5’GACCAGAGCCCCTTAGCTTC 3’ 340 DRG  
    RW: 5’TGCAGCTTCCGAGTCACAAT 3’     
5-HT2A  NM_172812 FW: 5’ CATCTCCCTGGACCGCTAC 3’ 150 DRG 
    RW: 5’ TCATCCTGTAGCCCGAAGAC 3’     
5-HT2B  XM_006529146 FW: 5’ CCGATTGCCCTCTTGACAAT 3’ 120 DRG 
    RW: 5’ GGCACAGAGATGCATGATGG 3’     
5-HT2C  NM_008312 FW: 5’ TGAAACTGGTTGCTTAAAACTGA 3’ 126 DRG  
    RW: 5’ AGCTGCTACTGGACTTATGGA 3’     
5-HT3A  NM_013561 FW: 5’ CCACCTTCCAAGCCAACAAG 3’ 128 DRG 
    RW: 5’ CTCCCTTGGTGGTGGAAGAG 3’     
5-HT3B  NM_020274 FW: 5’ TGATTCTTCTGTGGTCCTGC 3’ 154 DRG 
    RW: 5’ GCCTCAGCCCAGTTGTAAAC 3’     
5-HT4  NM_008313 FW: 5’ ATGTTCTGCCTGGTCCGG 3’ 162  DRG 
    RW: 5’ GCCTCCCAACATTAATGCGA 3’     
5-HT5A  NM_008314 FW: 5’ AAGACCAACAGCGTCTCCC 3’ 124 Brain 
    RW: 5’ TCCACGTATCCCCTTCTGTC 3’     
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5-HT5B NM_010483 FW: 5’  TCTCCTTCGACGTGTTGTGC 3’ 469  Brain 
    RW: 5’  GAGTCTCCGCTTGTCTGGAA 3’     
5-HT6 NM_021358 FW: 5’  TGGGCAAAGCTCGAACATCT 3’ 386 Brain 
    RW: 5’  GTCACATACGGCCTGAGCTAT 3’     
5-HT7 NM_008315 FW: 5’  AAGTTCTCAGGCTTCCCACG 3’    485 DRG  
    RW: 5’  CAGTTTTGTAGCACAAACTCGCT 3’     
TPH1  NM_009414 FW: 5’  CTAGGAGTTCATGGCAGGTG3’ 83 Duodenum 
    RW: 5’ TTTCGAGTCTTTCACTGCACT 3’     
TPH2  NM_173391 FW: 5’ TTCCCAGGGTCGAGTACACA 3’ 216 Brain 
    RW: 5’ GTCTCTTGGGCTCAGGTAGC 3’     
SERT NM_010484 FW: 5’ CATAGCCAATGACAGACAG 3’ 352 Duodenum 
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Figures legends 
 
Figure 1. Intravesically applied 5-HT, 2-Me-5HT and 5-MT stimulated bladder 
afferent firing. (A) Representative trace to illustrate the afferent response to 
intravesical application of 5-HT (100 µM). (B-D) The peak afferent response to 
intravesical application of (B) 5-HT (100 µM), (C) 2-Me-5HT (100 µM) and (D) 5-MT 
(100 µM). Overall, 5-HT, 2-Me-5-HT and 5-MT all evoked increased in afferent firing 
above baseline (*P<0.05), paired Student’s t-test. Each dot represents data from a 
single preparation (N).  
 
 
This article is protected by copyright. All rights reserved. 
 
Figure 2. mRNA expression of 5-HT receptors, TPH1, TPH2, and SERT on the 
mouse urothelium. An array of 5-HT receptor transcripts were detected in mouse 
urothelial cell lysates (5-HT1A, 1B, 1D, 2A, 2B, 4, 6, 7).  5-HT1F, 2C, 3A, 3B, 5A, and 5B 
receptors were not detectable. mRNA expression of TPH1, TPH2, and SERT were 
detected in mouse urothelial cells. ß-actin was used as a house keeping gene. 
Duodenum was used as a positive control of TPH1 and SERT. Brain was used as a 
positive control for TPH2 (N=3 mice per tissue). 
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Figure 3. 5-HT stimulated mouse urothelial cells through a non-5-HT3 receptor 
mechanism. (A) A sample trace showing the calcium response of isolated primary 
mouse urothelial cells to 5-HT (100 μM) and ionomycin (5 μM) . Each line represents 
a single urothelial cell. B) The relative increase of intracellular Ca2+(Ratio 340/380) in 
response to 5-HT with and without preincubation with granisetron (1 µM), showing 
that granisetron did not affect 5-HT repsonses. (C) The percentage of cells 
responding to 5-HT after pre-incubation of granisetron, paired Student’s t-test, (5-HT, 
N=6 mice, n=137 cells vs. Granisetron with 5-HT, N=5 mice, n=115 cells), unpaired 
Student’s t-test. N refers to number of animals and n indicates number of cells. 
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Figure 4. 5-HT3 receptors play a role in mediating the action of 5-HT on bladder 
afferent firing and this effect is independent of detrusor contraction. (A) A 
representative trace showing the effect of bath applied 5-HT on afferent nerve firing 
and detrusor tone. 5HT, 2-Me-5-HT and 5-MT all evoked an increase in nerve firing 
which was concomitant with a small but significant bladder contraction. (B) The 
afferent response to bath application of 5-HT, 2-Me-5-HT, 5-MT with and without pre-
incubation of the 5-HT3 receptor antagonist granisetron and/or smooth muscle 
blockers (Y-27632 and ML-9) (C) The effect of the same pharmacological agents on 
detrusor contractility. Data are represented as mean +/- SEM, each symbol 
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represents a single N number,  *P<0.05, **P<0.01, ***P<0.001, One-way ANOVA 
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Figure 5. Mice with chronic visceral hypersensitivity (CVH) evoked by TNBS 
had increased spontaneous afferent firing and hypersensitivity in response to 
bladder distension. This effect was partially reversed by application of 
granisetron. (A). Afferent firing from bladders taken from sham mice, mice with 
acute visceral hypersensitivity (AVH) and mice with chronic visceral hypersensitivity 
(CVH), showing that firing rate was higher with chronic visceral hypersensitivity and 
partially rescued by application of the 5HT3 receptor antagonists granisetron. (B). 
The afferent response to bladder filling in bladders taken from sham mice, mice with 
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acute visceral hypersensitivity (AVH) and mice with chronic visceral hypersensitivity 
(CVH) showing that firing rate was higher with chronic visceral hypersensitivity and 
partially rescued by application of the 5HT3 receptor antagonists granisetron. 
*P<0.05, and One-way ANOVA with Dunnett’s multiple comparison and Two-way 
ANOVA respectively (healthy control and CVH, N=6; acute TNBS, N=5; CVH, N=6; 
CVH+granisetron, N=6). (C). The afferent response to bladder filling in bladders 
taken from normal control mice before and after application of granisetron. These 
data show that in bladders taken from healthy control animals granisteron has no 





Figure 6 SERT mRNA expression in the urothelium was significantly attenuated in mice 
with CVH. (A) SERT mRNA expression was significantly reduced in urothelial cell cultures 
from CVH animals compared to control animals (*P<0.05, unpaired Student’s t-test healthy 
control; N=4, CVH; N=6). (B) TPH1 and (C) TPH2 mRNA expression was not significantly 
altered. (NS, unpaired Student’s t-test healthy control; N=4, CVH; N=6). 
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Figure 7. 5-HT and 2-Me-5HT induce calcium transients in bladder-innervating 
DRG neurons. (A) A high percentage of bladder projecting DRG neurons in both 
sham (91%) and mice with CVH (95%) express 5-HT3 receptors (sham, N=3, n=77; 
CVH, N=3, n=74; N refers to number of animals, n indicates number of DRG 
neurons). (B) Calcium responses elicited by 5-HT (100 µM) and 2-Me-5HT (100 µM) 
from isolated bladder-innervating (traced), and non-traced LS DRG neurons. Each 
line represents an individual neuron. Bladder traced neurons are represented in blue, 
non-traced neurons are represented in black, and responding non-traced neurons 
are represented in orange. (C) Table showing number of bladder-innervating and 
non-traced LS DRG neurons responding to 5-HT (100 µM) (N=4 mice) and 2-Me-
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5HT (100 µM) (N=4 mice). The percentage of bladder-innervating neurons 
responding to either to 5-HT and 2-Me-5HT is greater than responding neurons from 
the general DRG population. (D) Maximum change in fluorescent ratio (F340/380) of 
individual neurons in response to 5-HT and 2-Me-5HT in bladder-innervating (blue 
dots) and non-traced (orange dots) LS DRG. The magnitude of the calcium response 
elicited by 5-HT (100 µM) is equivalent to that elicited by 2-Me-5HT (100µM) for both 
bladder-innervating DRGs (p≥0.05, One-way ANOVA, Tukey post-hoc test) and in 
the non-traced DRGs (p≥0.05, One-way ANOVA, Tukey post-hoc test).  
 
